Dosimetry for Y-90 Radioembolization using a Long axial Field of View PET/CT scanner: Impact of Image Reconstruction and Scan Duration on Determined Absorbed Dose and Compliance with Prescribed Dose
Nuklearmedizin - NuclearMedicine · 01.03.2025 · 64 (01) · 112
DOI: 10.1055/s-0045-1804469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.03.2025. Verfasst von E Körner und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Ziel/Aim: The increased sensitivity of long axial field of view (LAFOV) PET/CT scanners compensates for the low branching ratio of Y-90, enabling accurate dosimetry. Here, we evaluate the impact of variations in the image reconstruction towards a shorter scan time on dose maps and assess the compliance of prescribed and absorbed doses. Methodik/Methods: 19 patients (6 NET, 5 CRC, 2 HCC, 2 lung cancer, 2 breast cancer, 1 ICC, 1 CUP) receiving a total of 27 treatment cycles underwent 30 min scans on a Siemens Biograph Vision Quadra® LAFOV PET/CT 15 to 43 h post radioembolization. Image reconstruction was varied between iterations of 2i5s and 4i5s for 30 and 20 min (rebinned) listmode data. Dose maps generated via a Monte Carlo simulated dose kernel were analyzed for mean dose (D mean ) in tumor, parenchyma and total liver. Dose-volume histogram (DVH) metrics (D75, D50, V40) of one patient supported the evaluation. D mean was assessed to determine compliance (± 10%) with prescribed doses. Ergebnisse/Results: Increasing iterations from 2i5s to 4i5s resulted in a mean deviation of D mean by 2.0±1.1% (tumor), 1.8±3.0% (parenchyma) and 0.8±1.3% (total liver). Maximum change in D mean was 5.7% (tumor), -11.1% (parenchyma) and 4.2% (total liver). Reduction of scan time to 20 min resulted in a mean deviation of D mean by 0.6±0.6% (tumor), 0.7±1.2% (parenchyma) and 0.7±1.1% (total liver). Maximum change in D mean was -1.6% (tumor), 4.0% (parenchyma) and 4.2% (total liver). The exemplary patient’s tumor had a D50 of 144 Gy (2i5s) and 145 Gy (4i5s), a D75 of 110 Gy (2i5s) and 108 Gy (4i5s), and liver V40 was 51.8% (2i5s) and 50.6% (4i5s). Comparison with prescribed doses showed compliance for tumor and parenchyma in 31% of the patients. In 44%, D mean in the tumor did not meet the prescribed dose (mean deviation -34.3±14.8%). In 33%, parenchymal dose limits were exceeded (mean deviation 46.4±35.5%; maximum deviation 63 Gy vs 30 Gy; all
Zitieren
APA
Körner, E., Linder, P., Brosch-Lenz, J., Lan, W., Dittmann, H., Fougère, C. L., & Schmidt, F. (2025). Dosimetry for Y-90 Radioembolization using a Long axial Field of View PET/CT scanner: Impact of Image Reconstruction and Scan Duration on Determined Absorbed Dose and Compliance with Prescribed Dose. Nuklearmedizin - NuclearMedicine, 64(01), 112. https://doi.org/10.1055/s-0045-1804469
Vancouver
Körner E, Linder P, Brosch-Lenz J, Lan W, Dittmann H, Fougère CL, et al. Dosimetry for Y-90 Radioembolization using a Long axial Field of View PET/CT scanner: Impact of Image Reconstruction and Scan Duration on Determined Absorbed Dose and Compliance with Prescribed Dose. Nuklearmedizin - NuclearMedicine. 2025;64(01):112. doi:10.1055/s-0045-1804469
BibTeX
@article{Krner2025,
author = {Körner, E and Linder, P and Brosch-Lenz, J and Lan, W and Dittmann, H and Fougère, C la and Schmidt, F},
title = {Dosimetry for Y-90 Radioembolization using a Long axial Field of View PET/CT scanner: Impact of Image Reconstruction and Scan Duration on Determined Absorbed Dose and Compliance with Prescribed Dose},
journal = {Nuklearmedizin - NuclearMedicine},
year = {2025},
volume = {64},
number = {01},
pages = {112},
doi = {10.1055/s-0045-1804469}
}
EUVIMED